Evidence map›Paper›PMID 33075216›Full record

ArticleJournal of diabetes investigation2021

Simple risk score to screen for prediabetes: A cross-sectional study from the Qatar Biobank cohort.

Mostafa Abbas, Raghvendra Mall, Khaoula Errafii, Abdelkader Lattab, Ehsan Ullah, Halima Bensmail, Abdelilah Arredouani

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Journal of diabetes investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Prediabetes in Syria and Its Associated Factors: A Single-Center Cross-Sectional Study.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mostafa AbbasQatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Raghvendra MallQatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Khaoula ErrafiiQatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Abdelkader LattabQatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Ehsan UllahQatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Halima BensmailQatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Abdelilah ArredouaniQatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.ORCID https://orcid.org/0000-0002-5060-916X
Hamad bin Khalifa University · QAGeisinger Medical Center · US

Funding

Qatar Foundation
6 · The paper itself

Abstract

AIMS/

introductionThe progression from prediabetes to type 2 diabetes is preventable by lifestyle intervention and/or pharmacotherapy in a large fraction of individuals with prediabetes. Our objective was to develop a risk score to screen for prediabetes in the Middle East, where diabetes prevalence is one of the highest in the world. MATERIALS AND

methodsIn this cross-sectional, case-control study, we used data of 4,895 controls and 2,373 prediabetic adults obtained from the Qatar Biobank cohort. Significant risk factors were identified by logistic regression and other machine learning methods. The receiver operating characteristic was used to calculate the area under curve, cut-off point, sensitivity, specificity, positive and negative predictive values. The prediabetes risk score was developed from data of Qatari citizens, as well as long-term (≥15 years) residents.

resultsThe significant risk factors for the Prediabetes Risk Score in Qatar were age, sex, body mass index, waist circumference and blood pressure. The risk score ranges from 0 to 45. The area under the curve of the score was 80% (95% confidence interval 78-83%), and the cut-off point of 16 yielded sensitivity and specificity of 86.2% (95% confidence interval 82.7-89.2%) and 57.9% (95% confidence interval 65.5-71.4%), respectively. Prediabetes Risk Score in Qatar performed equally in Qatari nationals and long-term residents.

conclusionsPrediabetes Risk Score in Qatar is the first prediabetes screening score developed in a Middle Eastern population. It only uses risk factors measured non-invasively, is simple, cost-effective, and can be easily understood by the general public and health providers. Prediabetes Risk Score in Qatar is an important tool for early detection of prediabetes, and can help tremendously in curbing the diabetes epidemic in the region.

Indexed as

AdolescentAdultAgedAged, 80 and overArea Under CurveBiological Specimen BanksBlood PressureBody Mass IndexCase-Control StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleHumansMaleMass ScreeningMiddle AgedPrediabetesQatar BiobankRisk score

Identifiers

PMID33075216
PMCPMC8169357
OpenAlexW3092920889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.